Entering into joint venture contracts between Shanghai Zuquan Investment Management Company Limited on one side and Epygon, Kephalios and MyoPowers on the other side.
Recent Posts
-
Presentation at LSI Europe ’24
Emerging MedTech Summit 2024 (Lisbon)
Sébastien Ladet, CEO -
Interview with Dr. Sarraf
Epygon: A unique device for mitral valve repair - Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
- Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
- Spécialiste produit – Urologie
Recent Comments